Syndax Pharmaceuticals Inc
SNDX
Revenue
20.04M
▲7.54M▲60.34%
6 Months ChangeAssets
640.71M
▼-84.11M▼-11.60%
3 Months ChangeLiabilities
425.65M
▼-11.04M▼-2.53%
3 Months ChangeFree Cash Flow
-20.04M
▼-20.04M-∞%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-01
Form 10-Q
ID: 0000950170-24-089241
2024-08-01
Form 8-K
ID: 0000950170-24-089235
2024-05-15
Form 8-K
ID: 0000950170-24-060462
2024-05-08
Form 10-Q
ID: 0000950170-24-055053
2024-05-08
Form 8-K
ID: 0000950170-24-055052
2024-03-18
Form 8-K
ID: 0000950170-24-032514
2024-02-27
Form 8-K
ID: 0000950170-24-021086
2023-12-20
Form 8-K
ID: 0000950170-23-071749
2023-12-15
Form 8-K
ID: 0001193125-23-296814
2023-12-12
Form 8-K
ID: 0000950170-23-069683